4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0000950170-24-006700
Options or other derivatives
- Interim CEO acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hogue Dale Curtis Jr. Interim CEO | 2024-01-20 | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | D | ||
Loading xslF345X05/ownership.xml…